Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Upadacitinib effectively treats psoriasis and lichen planus together.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib is effective and safe for treating severe alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.